I. Bernstein

I. Bernstein, M. V. D. van den Brink, R. Boyd, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Enhanced Posttransplant T Cell Reconstitution With Interleukin-7 , Keratinocyte Growth Factor , and Lymphoid Precursors

I. Bernstein, S. Heimfeld, R. Boyd, 2022 .

CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons

I. Bernstein, E. Bryant, W. Bensinger, 1992 .

Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

I. Bernstein, B. Zbar, H. Rapp, 1970, Science.

Notch blockade overcomes endothelial cell-mediated resistance of FLT3/ITD-positive AML progenitors to AC220 treatment

B. Hadland, I. Bernstein, S. Meshinchi, 2020, Leukemia.

Monoclonal antibody therapy of murine lymphoma: enhanced efficacy by concurrent administration of interleukin 2 or lymphokine-activated killer cells.

I. Bernstein, P. Greenberg, D. Peace, 1990, Cancer research.

Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen.

I. Bernstein, C. Nourigat, C. Badger, 1990, Journal of the National Cancer Institute.

Positive selection of hematopoietic progenitors from marrow and peripheral blood for transplantation.

I. Bernstein, E. Thomas, W. Bensinger, 1990, Journal of clinical apheresis.

Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts.

I. Bernstein, J. Eary, W. Nelp, 1990, Cancer research.

131 I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in ﬁrst remission

I. Bernstein, J. Eary, F. Appelbaum, 2006 .

Leukocyte Typing II

I. Bernstein, B. Haynes, E. Reinherz, 1986, Springer New York.

Cell‐mediated reactivity to antigens shared by moloney‐virus‐induced lymphomas (LSTRA) and certain 3‐methylcholanthrene‐induced mouse sarcomas

I. Bernstein, J. Brown, I. Hellstrom, 1979, International journal of cancer.

Tumor hnmunity: Tumor Suppression in vivo Initiated by Soluble Products of Specifically Stimulated Lymphocytes

I. Bernstein, B. Zbar, H. Rapp, 1971, Science.

Delineation of the minimal commonly deleted segment and identification of candidate tumor‐suppressor genes in del(9q) acute myeloid leukemia

Zheng Zhao, I. Bernstein, N. Heerema, 2005, Genes, chromosomes & cancer.

ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial

I. Bernstein, S. Raimondi, S. Meshinchi, 2019, Blood Cancer Journal.

Infusion of a non-HLA-matched ex-vivo expanded cord blood progenitor cell product after intensive acute myeloid leukaemia chemotherapy: a phase 1 trial.

I. Bernstein, E. Estey, F. Appelbaum, 2016, The Lancet. Haematology.

CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons.

I. Bernstein, E. Bryant, W. Bensinger, 1992, Blood.

Inhibition of granulocytic differentiation by mNotch1.

I. Bernstein, A. Bigas, Raphael Kopan, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of combinations of interferons with tumor specific and nonspecific monoclonal antibodies as therapy for murine B- and T-cell lymphomas.

I. Bernstein, T. Merigan, M. Palladino, 1988, Cancer research.

M1 and M2 macrophages differentially regulate hematopoietic stem cell self-renewal and ex vivo expansion.

I. Bernstein, P. Emanuel, Y. L. Liu, 2018, Blood advances.

Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1Ext-IgG

I. Bernstein, C. Delaney, C. Brashem-Stein, 2014, Leukemia.

Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.

I. Bernstein, F. Appelbaum, D. Fisher, 1999, Blood.

131 I-Anti-CD45 Antibody Plus Busulfan/Cyclophosphamide in Matched Related Transplants for Acute Myeloid Leukemia in First Remission.

I. Bernstein, J. Eary, F. Appelbaum, 2004 .

Normal immunologic response to a neoantigen, bacteriophage phiX-174, in baboons with long-term lymphohematopoietic reconstitution from highly purified CD34+ Lin- allogeneic marrow cells.

I. Bernstein, H. Ochs, E. Bryant, 1997, Blood.

Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass.

I. Bernstein, J. Hansen, C. Anasetti, 1987, Journal of immunology.

Serotherapy of malignant disease.

I. Bernstein, P. W. Wright, 1976, Progress in experimental tumor research.

Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.

I. Bernstein, R. Humphries, H. Kiem, 2010, Blood.

Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors.

James J Collins, Sergei Doulatov, Leonard I Zon, 2013, Cell stem cell.

Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.

D. Hirschstein, I. Bernstein, D. Williams, 1996, Experimental hematology.

Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.

I. Bernstein, F. Appelbaum, J. Pagel, 2008, Blood.

Breast cancer resistance protein (BCRP/ABCG2) does not confer resistance to gemtuzumab ozogamicin and calicheamicin-γ1 in acute myeloid leukemia cells

I. Bernstein, H. Kiem, R. Walter, 2004, Leukemia.

High-dose radioimmunotherapy of lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1993, Cancer treatment and research.

Alteration of lymphoid cells in AKR mice by treatment with monoclonal antibody against Thy-1 antigen.

I. Bernstein, R. Nowinski, M. Tam, 1982, Transplantation.

Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen.

I. Bernstein, R. Nowinski, M. Tam, 1980, Science.

Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma.

I. Bernstein, J. Eary, K. Krohn, 1997, Nuclear medicine and biology.

Radiolabeled antibody therapy of lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1995, Important advances in oncology.

Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus.

I. Bernstein, B. Varnum-Finney, M. Dallas, 2008, Blood.

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.

S. A. Bush, I. Bernstein, J. Eary, 2003, Blood.

Treatment of malignancy with unmodified antibody.

I. Bernstein, C. Anasetti, J. Davis, 1987, Pathology and immunopathology research.

Phase I study of 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas

I. Bernstein, J. Eary, W. Nelp, 1995, The Lancet.

Bone marrow transplantation for acute non-lymphocytic leukemia: a report from the Childrens Cancer Study Group of sixty-seven children transplanted in first remission.

I. Bernstein, S. Feig, J. Buckley, 1987, Bone marrow transplantation.

Improving the tumor retention of radioiodinated antibody

I. Bernstein, J. Eary, W. Nelp, 1990 .

Learned food aversions and cancer anorexia.

I. Bernstein, I. Bernstein, 1981, Cancer treatment reports.

A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.

S. A. Bush, I. Bernstein, J. Eary, 2000, Blood.

Is there a better way to deliver total body irradiation?

I. Bernstein, H. Deeg, J. Eary, 1992, Bone marrow transplantation.

WR2721 protection of bone marrow in 131I-labeled antibody therapy.

I. Bernstein, J. Rasey, D. Fisher, 1991, Radiation research.

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen

I. Bernstein, C. Badger, 1983, The Journal of experimental medicine.

Monoclonal antibody therapy of murine leukemia. Abstr.

I. Bernstein, C. Badger, 1982 .

Monoclonal Antibody Therapy of Mouse Leukemia

I. Bernstein, E. Clark, B. Mcmaster, 1980 .

Serotherapy of malignant disease.

I. Bernstein, K. Hellström, I. Hellström, 1976, The Medical clinics of North America.

Monoclonal Antibody Therapy of Murine Lymphoma: Enhanced Efficacy by Concurrent Administration of Interleukin 2 or Lymphokine-activated Killer Cells1

I. Bernstein, P. Greenberg, Christopher, 2006 .

Lymphokine-activated Killer Cells Efficacy by Concurrent Administration of Interleukin 2 or Monoclonal Antibody Therapy of Murine Lymphoma : Enhanced Updated

I. Bernstein, P. Greenberg, D. Peace, 2006 .

Monoclonal Antibody Therapy of Murine Lymphoma : Enhanced Efficacy by Concurrent Administration of Interleukin 2 or Lymphokine-activated Killer Cells 1

I. Bernstein, P. Greenberg, Christopher, 2006 .

Stages of Myeloid Differentiation Identified by Monoclonal Antibodies

I. Bernstein, B. Torok-Storb, R. Andrews, 1984 .

Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin.

I. Bernstein, B. Zbar, H. Rapp, 1971, Journal of the National Cancer Institute.

Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics

B. Hadland, I. Bernstein, S. Rafii, 2022, Nature Communications.

The effect of long-term marrow culture on the origin of colony-forming cells in acute myeloblastic leukemia: studies of two patients heterozygous for glucose-6-phosphate dehydrogenase.

I. Bernstein, J. Singer, P. Fialkow, 1988, Leukemia.

MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia.

I. Bernstein, J. Buckley, W. Woods, 1997, Blood.

PASSIVE IMMUNOTHERAPY WITH MONOCLONAL ANTIBODIES TO DIFFERENTIATION ANTIGENS

I. Bernstein, E. Denkers, C. Badger, 1985 .

Impaired inflammatory response in tumor-bearing guinea pigs.

I. Bernstein, B. Zbar, H. Rapp, 1972, Journal of the National Cancer Institute.

Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling

Matthew C. Canver, L. Zon, R. White, 2015, eLife.

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

I. Bernstein, R. Arceci, T. Alonzo, 2002, Blood.

Lymphangiomatosis with chylothorax.

I. Bernstein, H. Ochs, F. Berberich, 1975, The Journal of pediatrics.

Immunologic defenses against cancer.

I. Bernstein, 1973, The Journal of pediatrics.

BLOCKING FACTORS IN TUMOR IMMUNITY AND ALLOGRAFT TOLERANCE

I. Bernstein, K. Hellström, I. Hellström, 1974 .

Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells.

I. Bernstein, B. Zbar, H. Rapp, 1971, Journal of the National Cancer Institute.

A granulocyte reactive monoclonal antibody, 1G10, identifies the Gal beta 1-4 (Fuc alpha 1-3)GlcNAc (X determinant) expressed in HL-60 cells on both glycolipid and glycoprotein molecules.

I. Bernstein, S. Hakomori, D. Urdal, 1983, Blood.

Maturation of hematopoietic stem cells from prehematopoietic stem cells is accompanied by up-regulation of PD-L1

B. Hadland, I. Bernstein, Long Gao, 2018, The Journal of experimental medicine.

Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor.

I. Bernstein, K. Zsebo, V. Broudy, 1992, Blood.

Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity.

I. Bernstein, R. Andrews, S. Rowley, 1993, Blood.

Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance.

I. Bernstein, J. Buckley, W. Woods, 1992, Blood.

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.

I. Bernstein, S. Feig, J. Buckley, 1992, Medical and pediatric oncology.

Glycolipid Specificities of Anti-Hematopoietic Cell Antibodies

I. Bernstein, S. Hakomori, B. Mcmaster, 1986 .

Nonlymphoblastic Leukemia-Associated Antigens Identified by Monoclonal Antibodies

I. Bernstein, R. Andrews, 1985 .

Immunodiagnosis of childhood ALL with monoclonal antibodies to myeloid and lymphoid associated antigens.

I. Bernstein, P. Dinndorf, D. Ridgway, 1985, Leukemia research.

Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies

I. Bernstein, B. Torok-Storb, R. Andrews, 1983 .

Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies.

I. Bernstein, B. Torok-Storb, R. Andrews, 1983, Blood.

A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons.

I. Bernstein, K. Zsebo, F. Appelbaum, 1992, Blood.

Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates

I. Bernstein, K. Zsebo, F. Appelbaum, 1991 .

Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor.

I. Bernstein, K. Zsebo, R. Andrews, 1991, Blood.

Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia

I. Bernstein, S. Raimondi, R. Ries, 2019, Clinical Cancer Research.

cooperative trials for de novo AML patients with core binding factor AML enrolled on serial pediatric mutations in pediatric KIT Prevalence and prognostic significance of

I. Bernstein, S. Raimondi, J. Radich, 2011 .

Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.

I. Bernstein, S. Raimondi, J. Radich, 2010, Blood.

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

I. Bernstein, J. Radich, J. Buckley, 2001, Blood.

Talen Mediated Therapeutic Gene Editing Strategy for ß-Hemoglobinopathies

I. Bernstein, A. Scharenberg, D. Rawlings, 2017 .

Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates.

I. Bernstein, K. Zsebo, F. Appelbaum, 1991, Blood.

Current status of the biology and treatment of acute non-lymphocytic leukemia in children (report from the ANLL strategy group of the Children's Cancer Study Group.

I. Bernstein, S. Feig, A. Bleyer, 1983, Blood.

Notch-HES1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells.

I. Bernstein, G. Daley, A. Schnerch, 2013, Blood.

All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells.

I. Bernstein, S. Collins, L. Purton, 2000, Blood.

All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors.

I. Bernstein, S. Collins, L. Purton, 1999, Blood.

Normal Immunologic Response to a Neoantigen , Bacteriophage F X-174 , in Baboons With Long-Term Lymphohematopoietic Reconstitution From Highly Purified CD 34

I. Bernstein, H. Ochs, E. Bryant, 1997 .

HEMATOPOIESIS AND STEM CELLS Notch-HES 1 signaling axis controls hemato-endothelial fate decisions of human embryonic and induced pluripotent stem cells

I. Bernstein, G. Daley, A. Schnerch, 2013 .

The Notch Pathway: Modulation of Cell Fate Decisions in Hematopoiesis

I. Bernstein, K. Ohishi, B. Varnum-Finney, 2002, International journal of hematology.

Notch signalling in hematopoiesis.

I. Bernstein, H. Shiku, K. Ohishi, 2003, Seminars in cell & developmental biology.

The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells.

I. Bernstein, R. Serda, C. Anasetti, 2001, Blood.

Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling.

I. Bernstein, J. Griffin, L. Wu, 2000, Journal of cell science.

Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.

I. Bernstein, C. Anasetti, K. Ohishi, 2000, Blood.

The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells.

I. Bernstein, S. Artavanis-Tsakonas, K. Moore, 1998, Blood.

Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability.

I. Bernstein, B. Varnum-Finney, C. Brashem-Stein, 2003, Blood.

Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling

I. Bernstein, W. Pear, Lanwei Xu, 2000, Nature Medicine.

A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors.

I. Bernstein, Raphael Kopan, L. Milner, 1994, Blood.

Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells

I. Bernstein, B. Varnum-Finney, M. Dallas, 2005, The Journal of experimental medicine.

Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity.

I. Bernstein, E. Laurenti, A. Trumpp, 2008, Cell stem cell.

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.

I. Bernstein, E. Estey, F. Appelbaum, 2012, Blood.

Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis.

Adam A. Margolin, W. L. Ruzzo, B. Hadland, 2017, Cell reports.

Transmembrane protein 88: a Wnt regulatory protein that specifies cardiomyocyte development

B. Hadland, I. Bernstein, R. Moon, 2013, Development.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution

Colleen Delaney, I. Bernstein, S. Heimfeld, 2010, Nature Medicine.

Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.

I. Bernstein, S. Raimondi, S. Meshinchi, 2008, Blood.

FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.

I. Bernstein, J. Radich, S. Meshinchi, 2006, Blood.

FLT 3 internal tandem duplication in CD 34 / CD 33 precursors predicts poor outcome in acute myeloid leukemia

I. Bernstein, J. Radich, S. Meshinchi, 2006 .

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

I. Bernstein, J. Radich, R. Arceci, 2003, Blood.

Engineering a niche supporting hematopoietic stem cell development using integrated single-cell transcriptomics

B. Hadland, I. Bernstein, S. Rafii, 2021, Nature Communications.

NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells

L. Zon, B. Hadland, I. Bernstein, 2018, Nature Communications.

Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment

Hao Yuan Kueh, George Freedman, Ellen V Rothenberg, 2016, Nature Immunology.

Molecular alterations of the IDH1 gene in AML: a Children’s Oncology Group and Southwest Oncology Group study

I. Bernstein, S. Raimondi, J. Radich, 2010, Leukemia.

Conditioning regimens in bone marrow transplantation

I. Bernstein, R. Storb, B. Sandmaier, 1991 .

Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.

I. Bernstein, P. Sorensen, S. Korsmeyer, 1994, The Journal of clinical investigation.

E47 Controls the Developmental Integrity and Cell Cycle Quiescence of Multipotential Hematopoietic Progenitors1

I. Bernstein, C. Milcarek, L. Kardava, 2008, The Journal of Immunology.

CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531.

I. Bernstein, S. Raimondi, S. Meshinchi, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood stem cell fate regulation by Delta-1-mediated rewiring of IL-6 paracrine signaling.

I. Bernstein, P. Zandstra, E. Csaszar, 2014, Blood.

The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas

Joel I. Pritchard, I. Bernstein, J. Olson, 2004, Cancer Research.

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

I. Bernstein, S. Heimfeld, C. Turtle, 2010, Blood.

ITIM‐dependent endocytosis of CD33‐related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2

Jonathan A. Cooper, I. Bernstein, Rong Zeng, 2008, Journal of leukocyte biology.

Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activity

I. Bernstein, H. Dombret, A. Baruchel, 2010, Leukemia.

Influence of antibody isotype on passive serotherapy of lymphoma.

I. Bernstein, E. Denkers, J. Ledbetter, 1985, Journal of immunology.

Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.

I. Bernstein, F. Behm, S. Raimondi, 1996, Blood.

AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway.

I. Bernstein, F. Sigaux, V. Parietti, 2011, Blood.

Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsiveness.

I. Bernstein, R. Andrews, Diana Anderson, 1989, Blood.

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia.

J. Adamson, I. Bernstein, V. Najfeld, 1987, The New England journal of medicine.

Primitive human hematopoietic precursors express Bcl-x but not Bcl-2.

I. Bernstein, D. Hockenbery, Julie R. Park, 1995, Blood.

Seizures associated with vincristine sulfate therapy.

I. Bernstein, J. Hartmann, R. Chard, 1973, The Journal of pediatrics.

Generation of cytotoxic lymphocytes in mixed leukocyte culture by rat lymphoid cells.

I. Bernstein, P. W. Wright, 1976, Transplantation.

Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.

I. Bernstein, J. Eary, F. Appelbaum, 1995, Cancer treatment and research.

Absorption of antigens from the gastrointestinal tract.

I. Bernstein, Z. Óváry, 1968, International archives of allergy and applied immunology.

Antigen CD34+ marrow cells engraft lethally irradiated baboons.

I. Bernstein, W. Bensinger, C D Buckner, 1988, The Journal of clinical investigation.

The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.

I. Bernstein, D. Williams, J. Buckley, 1996, Blood.

Radioimmunotherapy strategies for non-Hodgkin's lymphomas.

I. Bernstein, J. Eary, O. Press, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

I. Bernstein, K. Ohishi, B. Varnum-Finney, 2002, The Journal of clinical investigation.

Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells.

Ian A. White, I. Bernstein, S. Rafii, 2010, Cell stem cell.

Antibody-directed therapies for hematological malignancies.

I. Bernstein, D. Maloney, M. Linenberger, 2002, Trends in molecular medicine.

Contrasting Roles for C/EBPα and Notch in Irradiation‐Induced Multipotent Hematopoietic Progenitor Cell Defects

I. Bernstein, Jihye Kim, A. Tan, 2015, Stem cells.

A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIa expressed on stored and activated platelets.

I. Bernstein, T. Kunicki, D. Nugent, 1987, Blood.

Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia.

I. Bernstein, S. Feig, J. Buckley, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

Irwin Hollander, I. Bernstein, H. Tsou, 2002, Bioconjugate chemistry.

Expression of normal myeloid-associated antigens by acute leukemia cells.

I. Bernstein, P. Dinndorf, R. Andrews, 1986, Blood.

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.

I. Bernstein, S. Raimondi, J. Radich, 2011, Blood.

Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells.

I. Bernstein, M. Berger, J. V. van Dongen, 2001, Blood.

Inaccessible LCG Promoters Act as Safeguards to Restrict T Cell Development to Appropriate Notch Signaling Environments

R. Sandstrom, J. Stamatoyannopoulos, I. Bernstein, 2021, Stem cell reports.

Gemtuzumab ozogamicin for acute myeloid leukemia.

I. Bernstein, F. Appelbaum, 2017, Blood.

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531.

I. Bernstein, S. Raimondi, R. Ries, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry.

I. Bernstein, J. Buckley, B. Lange, 1996, Journal of the National Cancer Institute.

Prevalence and prognostic significance of Flt 3 internal tandem duplication in pediatric acute myeloid leukemia

I. Bernstein, J. Radich, J. Buckley, 2000 .

CD33 as a target for selective ablation of acute myeloid leukemia.

I. Bernstein, 2002, Clinical lymphoma.

Transplantation with Enriched Stem Cell Fractions

I. Bernstein, W. Bensinger, C. Buckner, 1993 .

Characterization of an antigen expressed on activated human T cells and platelets.

I. Bernstein, D. Nugent, C. Brashem-Stein, 1988, Journal of immunology.

Blast colony-forming cells and precursors of colony-forming cells detectable in long-term marrow culture express the same phenotype (CD33- CD34+).

I. Bernstein, R. Andrews, M. Ogawa, 1991, Experimental hematology.

Ontogeny of hematopoietic stem cell development: reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitors.

I. Bernstein, F. Smith, R. Andrews, 1993, Blood.

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

I. Bernstein, P. Burke, R. Walter, 2013, Blood.

Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.

I. Bernstein, M. Litzow, R. Andrews, 1991, Blood.

Allograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexes.

I. Bernstein, R. Hargreaves, K. Hellström, 1973, Proceedings of the National Academy of Sciences of the United States of America.

Serological and biochemical analysis of the PlA1 alloantigen of human platelets

I. Bernstein, S. Slichter, R. Nowinski, 1982, British journal of haematology.

Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor.

I. Bernstein, K. Zsebo, V. Broudy, 1992, Blood.

The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors.

I. Bernstein, J. Singer, R. Andrews, 1986, Blood.

Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity.

Jonathan A. Cooper, I. Bernstein, D. Kamikura, 2004, Blood.

Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes

W. L. Ruzzo, Daniel C. Jones, B. Hadland, 2015, Journal of Cell Science.

Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes

W. L. Ruzzo, B. Hadland, I. Bernstein, 2015, Development.

Multipotent progenitors and hematopoietic stem cells arise independently from hemogenic endothelium in the mouse embryo

B. Hadland, I. Bernstein, S. Rafii, 2021, Cell reports.

Multipotent progenitors and hematopoietic stem cells arise independently during the endothelial to hematopoietic transition in the early mouse embryo

B. Hadland, I. Bernstein, S. Rafii, 2021, bioRxiv.

Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture.

B. Hadland, I. Bernstein, B. Varnum-Finney, 2018, Journal of visualized experiments : JoVE.

A Common Origin for B-1a and B-2 Lymphocytes in Clonal Pre- Hematopoietic Stem Cells

B. Hadland, I. Bernstein, S. Rafii, 2017, Stem cell reports.

Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells.

B. Hadland, I. Bernstein, S. Rafii, 2015, The Journal of clinical investigation.

In vitro detection of enhancing antibody by the macrophage migration test.

I. Bernstein, P. W. Wright, 1971, Nature: New biology.

Synergy among rat T cells in the proliferative response to alloantigen.

I. Bernstein, P. W. Wright, S. Loop, 1979, Cellular immunology.

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.

S. A. Bush, I. Bernstein, J. Eary, 2002, Blood.

Differences in the frequency of normal and clonal precursors of colony- forming cells in chronic myelogenous leukemia and acute myelogenous leukemia

I. Bernstein, V. Najfeld, J. Singer, 1992 .

All-trans retinoic acid facilitates oncoretrovirus-mediated transduction of hematopoietic repopulating stem cells.

I. Bernstein, S. Collins, H. Kiem, 2001, Journal of hematotherapy & stem cell research.

Murine hemogenic endothelial precursors display heterogeneous hematopoietic potential ex vivo.

B. Hadland, I. Bernstein, S. McKinney-Freeman, 2017, Experimental hematology.

Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia

I. Bernstein, S. Meshinchi, F. Appelbaum, 2014, Leukemia.

GATA‐1 is expressed in acute erythroblastic leukaemia

I. Bernstein, F. Smith, H. Ekert, 1994, British journal of haematology.

I-Anti-CD 45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

CELL‐MEDIATED REACTIVITY AND SERUM BLOCKING ACTIVITY IN TOLERANT RATS STUDIES ON TEN RATS OPERATIONALLY TOLERANT TO SKIN ALLOGRAFTS USING SEVERAL INDPENDENT ASSAYS

I. Bernstein, K. Hellström, P. W. Wright, 1974, Transplantation.

Monoclonal antibodies in the study and therapy of hematopoietic cancers

I. Bernstein, F. Smith, D. Matthews, 1992, Current Biology.

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target

B. Hadland, I. Bernstein, K. Loeb, 2022, The Journal of clinical investigation.

131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.

I. Bernstein, J. Eary, F. Appelbaum, 2006, Blood.

Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice.

I. Bernstein, K. Hellström, I. Hellström, 1979, Proceedings of the National Academy of Sciences of the United States of America.

Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.

A. V. Peterson, I. Bernstein, C. Badger, 1986, Cancer research.

High Dose Radiolabeled Antibody Therapy of Lymphoma 1

I. Bernstein, J. Eary, W. Nelp, 2006 .

Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.

A. V. Peterson, I. Bernstein, C. Badger, 1986, Cancer research.

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.

I. Bernstein, F. Appelbaum, D. Banker, 2004, Blood.

Therapy of Acute Leukemia with Monoclonal Antibodies and Immunoconjugates

I. Bernstein, E. Sievers, D. Matthews, 2003 .

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.

S. A. Bush, I. Bernstein, J. Eary, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.

I. Bernstein, J. Eary, F. Appelbaum, 1997, Cancer treatment and research.

Notch-Mediated Expansion of Human Cord Blood Progenitor Cells Results in Rapid Myeloid Reconstitution in Vivo Following Myeloablative Cord Blood Transplantation

I. Bernstein, S. Heimfeld, J. Gutman, 2008 .

Treatment of 11q23/MLL + AML with Gemtuzumab Ozogamicin: Results from the Randomized Phase III Children's Oncology Group Trial AAML0531

I. Bernstein, S. Raimondi, S. Meshinchi, 2015 .

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

I. Bernstein, R. Walter, M. Linenberger, 2003, Blood.

The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.

I. Bernstein, K. Zsebo, F. Appelbaum, 1992, Blood.

Effects of propylthiouracil on the biodistribution of an iodine-131-labeled anti-myeloid antibody in normal dogs: dosimetry and clinical implications.

I. Bernstein, J. Eary, B. Sandmaier, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity

A. Gnirke, I. Bernstein, R. Gottardo, 2015, Leukemia.

allogeneic baboons stable lymphopoiesis and myelopoiesis in lethally irradiated CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute

I. Bernstein, W. Bensinger, R. Andrews, 2011 .

Selected Presentations from the Meeting "Isolation of Human Hematopoietic Stem Cells, Stem Cell Expansion, and the Application of New Growth Factors" Held in St. Louis, Missouri, October 3, 1992

I. Bernstein, M. Pallavicini, E. Bryant, 1993 .

SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML

I. Bernstein, P. Burke, R. Walter, 2012 .

ozogamicin different resistance mechanisms to sensitize AML cells to gemtuzumab The peripheral benzodiazepine receptor ligand PK11195 overcomes

I. Bernstein, F. Appelbaum, D. Banker, 2013 .

Multidrug Resistance Protein ( MRP ) Attenuates Gemtuzumab Ozogamicin-Induced Cytotoxicity In Acute Myeloid Leukemia Cells Running head : MRP attenuates GO-induced cytotoxicity

I. Bernstein, R. Walter, M. Linenberger, 2003 .

that engraft lethally irradiated baboons The ligand for c-kit, stem cell factor, stimulates the circulation of cells

I. Bernstein, F. Appelbaum, W. Bensinger, 2011 .

NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness.

Matthew R Hart, I. Bernstein, S. Furlan, 2022, Blood.

Childhood Leukemias: Antibody-targeted therapy

I. Bernstein, E. Sievers, 2006 .

T cell synergy in the rat: serologic characterization of T cell subsets.

I. Bernstein, P. W. Wright, S. Loop, 1980, Journal of immunology.

The role of viral and cell-associated antigens in the cell-mediated immune response of rats to virus-induced lymphoma cells.

I. Bernstein, R. Nowinski, J. Stiefel, 1980, Journal of immunology.

Gene Conversion Is a Late Event in Evolution of High Risk AML.

I. Bernstein, J. Radich, S. Meshinchi, 2007 .

recognizes the human c-kit receptor Isolation and characterization of a monoclonal antibody that

I. Bernstein, V. Broudy, T. Papayannopoulou, 2011 .

DEV117010 3198..3209

W. L. Ruzzo, B. Hadland, I. Bernstein, 2015 .

Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.

I. Bernstein, Irwin D. Bernstein, 1977, Journal of immunology.

CBFA2T3-GLIS2 oncogenic fusion is sufficient for leukemic transformation

B. Hadland, I. Bernstein, K. Loeb, 2021 .

Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.

I. Bernstein, N. Flournoy, K. Krohn, 1986, Cancer research.

Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells.

I. Bernstein, B. Varnum-Finney, C. Delaney, 2005, Blood.

Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.

A. V. Peterson, I. Bernstein, P. W. Wright, 1978, Cancer treatment reports.

High dose radiolabeled antibody therapy of lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Cancer Research.

Post therapy imaging in high dose I-131 radioimmunotherapy patients.

K. R. Pollard, I. Bernstein, J. Eary, 1994, Medical physics.

Localized beta dosimetry of 131I-labeled antibodies in follicular lymphoma.

I. Bernstein, J. Weinstein, J. Eary, 1992, Medical physics.

High-Dose Radioimmunotherapy of B Cell Lymphomas1

I. Bernstein, J. Eary, W. Nelp, 1989 .

Potentiation of the in vitro specific cytotoxic response to syngeneic lymphoma cells by PPD-stimulated tuberculin sensitive cells.

I. Bernstein, O. Alaba, P. W. Wright, 1979, Cellular immunology.

Joint Report of the Myeloid Section of the Second International Workshop on Human Leukocyte Differentiation Antigens

I. Bernstein, S. Self, 1986 .

SIRT1 is dispensable for function of hematopoietic stem cells in adult mice.

I. Bernstein, C. Nourigat, Hongzhe Li, 2012, Blood.

Establishment of a pluripotent preleukaemic stem cell line by expression of the AML1‐ETO fusion protein in Notch1‐immortalized HSCN1cl10 cells

I. Bernstein, C. Delaney, 2004, British journal of haematology.

Generation of hematopoietic colony-forming cells from embryonic stem cells: synergy between a soluble factor from NIH-3T3 cells and hematopoietic growth factors.

I. Bernstein, A. Bigas, D I Martin, 1995, Blood.

Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.

I. Bernstein, P. W. Wright, E. Cohen, 1976, Journal of immunology.

Visualizing human ESC-derived hematopoiesis.

B. Hadland, I. Bernstein, 2013, Blood.

Expansion of Hematopoietic Stem Cells

I. Bernstein, C. Delaney, 2009 .

Progenitor cell involvement is predictive of response to induction chemotherapy in paediatric acute myeloid leukaemia

D. Johnston, I. Bernstein, J. Radich, 2003, British journal of haematology.

Tumor-growth suppression in vivo: cooperation between immune lymphoid cells sensitized in vitro and nonimmune bone marrow cells.

I. Bernstein, O. Alaba, 1978, Journal of immunology.

Engineering stem cell expansion.

I. Bernstein, C. Delaney, 2012, Cell stem cell.

Quantitative expression and function of differentiation antigens on normal and malignant lymphoid cells.

I. Bernstein, E. Clark, J. Ledbetter, 1985, Haematology and blood transfusion.

Recombinant Human Stem Cell Factor , a c-kit Ligand , Stimulates Hematopoiesis in Primates

I. Bernstein, K. Zsebo, F. Appelbaum, 2003 .

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.

I. Bernstein, J. Eary, W. Nelp, 1993, The New England journal of medicine.

Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties

I. Bernstein, R. Andrews, J. Singer, 1989, The Journal of experimental medicine.

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 acute myeloid leukemia patients

I. Bernstein, R. Arceci, T. Alonzo, 2002 .

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

I. Bernstein, R. Arceci, T. Alonzo, 2003, Blood.

Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony-forming cells when cultured with marrow stromal cells

I. Bernstein, R. Andrews, J. Singer, 1990, The Journal of experimental medicine.

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.

I. Bernstein, E. Estey, I. Bernstein, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.

I. Bernstein, F. Behm, G. Kitchingman, 1988, Leukemia.

Retention of B-cell-specific monoclonal antibodies by human lymphoma cells.

I. Bernstein, I. Bernstein, S. Anderson, 1994, Blood.

Imaging and treatment of B-cell lymphoma.

I. Bernstein, J. Eary, W. Nelp, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Distinct Transcriptional Signatures Distinguish the Emergence of Multipotent Progenitors and Hematopoietic Stem Cells from Endothelial Precursors in the Murine Embryo

B. Hadland, I. Bernstein, S. Rafii, 2020 .

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

I. Bernstein, I. Bernstein, J. Eary, 1996, Cancer research.

Seventy percent survival in childhood non-hodgkin’s lymphoma

I. Bernstein, J. Miser, A. Miser, 1980 .

Infusion of a Non HLA-Matched Off-the-Shelf Ex Vivo Expanded Cord Blood Progenitor Cell Product Following Myeloablative Cord Blood Transplantation Is Safe, Decreases the Time to Hematopoietic Recovery, and Results in Excellent Overall Survival

I. Bernstein, S. Heimfeld, F. Appelbaum, 2014 .

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

I. Bernstein, R. Arceci, T. Alonzo, 2002 .

I. Bernstein, F. Appelbaum, J. Pagel, 2008, Blood.

Antibody in Normal Dogs : Dosimetry and Clinical Implications Effects of Propylthiouracil on the Biodistribution of an Iodine-131-Labeled Anti-Myeloid

Darrell, I. Bernstein, J. Eary, 2006 .

Effects of Propyithiouracil on the Biodistribution of an Iodine-13 1-Labeled Anti-Myeloid Antibody in Normal Dogs : Dosimetry and Clinical Implications

I. Bernstein, J. Eary, B. Sandmaier, 2006 .

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a speciﬁc CD8 (cid:1) T-cell response against the nonengrafted unit

I. Bernstein, S. Heimfeld, C. Turtle, 2010 .

Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.

I. Bernstein, S. Raimondi, J. Radich, 2011, Blood.

Dose Dependent Enhancement Of Neutrophil Recovery By Infusion Of Notch Ligand Ex Vivo Expanded Cord Blood Progenitors: Results Of a Multi-Center Phase I Trial

I. Bernstein, S. Heimfeld, J. Wagner, 2013 .

ABSENCE OF SERUM BLOCKING ACTIVITY IN MICE IMMUNOLOGICALLY TOLERANT TO SOLUBLE HISTOCOMPATIBILITY-2 ANTIGENS

I. Bernstein, E. Appella, P. W. Wright, 1974, Transplantation.

I. Bernstein, J. Buckley, C. March, 1996, Blood.

I. Bernstein, J. Singer, R. Andrews, 1990, The Journal of experimental medicine.